Corporate
Corporate Statement
MicroMRI, Inc. is a medical device company focused on developing and commercializing novel and innovative products that perform high resolution Magnetic Resonance Imaging (MRI) of bone micro-architecture with subsequent detailed visualization of bone structural elements. The Company intends to develop a commercial product for routine clinical use that can be deployed as an add-on to currently available clinical MRI scanners.
It is the mission of MicroMRI to become the premier company for non-invasive visualization of bone micro-architecture.
Until recently, MRI as a modality had not been used for bone imaging because of technical limitations regarding signal and resolution. The technology originally developed at University of Pennsylvania has overcome these limitations and allowed for the first time the visualization of bone micro-architecture using high-signal, high resolution MRI. Since our founding in 2003 with a license to the technology from the University of Pennsylvania, MicroMRI has been steadily developing its proprietary post-processing software. In 2004 the Company won a $4M NIH SBIR grant to investigate the performance of our technology in a multicenter clinical trial. The Company has also executed contracts with several pharmaceutical companies to use its technology for contract research services during pharmaceutical industry sponsored clinical trials investigating new drug treatments. To date, more than 19 scientific papers have been published and multiple site initiated grants have been funded, highlighting the broad potential of the technology.
In January 2008, MicroMRI received its first FDA approval, a 510k clearance for the wrist coil.